Anticonvulsant profile and mechanism of action of propanolol and its two enantiomers

Seizure

Volumn 11, Issue 5, 2002, Pages 285-302

  Fischer, W ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

(+) and ( ) propranolol; Anticonvulsants; Propranolol; Seizure models; Sodium channel; Whole cell patch clamp

Indexed keywords

ANTICONVULSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; PENTETRAZOLE; PICROTOXIN; PROPRANOLOL; SODIUM CHANNEL BLOCKING AGENT;

AFTERDISCHARGE; AMYGDALOID NUCLEUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CELL CULTURE; CLONIC SEIZURE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DRUG CONFORMATION; DRUG EFFICACY; ELECTROCONVULSIVE THERAPY; ELECTRODE; ENANTIOMER; EVOKED CORTICAL RESPONSE; FOCAL EPILEPSY; GENERALIZED EPILEPSY; HEART MUSCLE CELL; HIPPOCAMPUS; MALE; NERVE CELL CULTURE; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; RAT; SCREENING TEST; SODIUM CURRENT; SPINAL CORD NERVE CELL; STRUCTURE ACTIVITY RELATION; TONIC SEIZURE;

EID: 0036630556     PISSN: 10591311     EISSN: None     Source Type: Journal    
DOI: 10.1053/seiz.2001.0644     Document Type: Article

References (86)

1. Propranolol
2. Beta-adrenergic blockers
3. Beta-adrenoceptor antagonists in psychiatry and neurology
4. Beta-rezeptorenblocker in der Neurologie und Psychiatrie
5. The role of β-adrenoceptor blockers in the treatment of psychiatric disorders
6. Pharmakologische Modulation noradrenerger und membranstabilisierender Mechanismen-Möglichkeiten zur Beeinflussung der Effektivität vonStandardantiepileptika
7. Zur antikonvulsiven Wirksamkeit von β-Adrenolytika beim Elektrokrampf
8. Anticonvulsant effects of propranolol and their pharmacological modulation
9. Antiepileptic drug mechanisms of action
10. Sodium channels as molecular targets for antiepileptic drugs
11. The anticonvulsant action of the (-)- and (+)-enantiomers of propranolol
12. Role of central β-adrenoceptors in the control of pentylenetetrazol-induced convulsions in rats
13. Central nervous system effects of four β-adrenergic receptor blocking agents
14. The anticonvulsant effects of propranolol and β-adrenergic blockade
15. Effect of β-ladrenoceptor antagonists and some related drugs on maximal electroshock seizures in mice
16. Possible synergistic anticonvulsant effect of propranolol and carbamazepine
17. Propranolol in startle induced epileptic seizures
18. The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. II. Maximal electroshock seizure models
19. A simplified method of evaluating dose-effect experiments
20. Comparative assays of antiepileptic drugs in mice and rats
21. Antiepileptic drug development: II. Anticonvulsant drug screening
22. Principles of drug action: Structure-activity relationships and mechanisms
23. Effect of catecholaminergic drugs on quinolinate- and kynurenine-induced seizures in mice
24. Antiepileptic drug development program
25. A note on a simple apparatus for detecting neurological deficit in rats and mice
26. Stereotaxic atlases for the cat, rabbit and rat
27. Anticonvulsant and sodium channel blocking activity of higher doses of clenbuterol
28. Comparative studies on the anticonvulsant effectiveness of nootropic drugs in kindled rats
29. Modification of seizure activity by electrical stimulation. II. Motor seizure
30. Differential α- and β-adrenergic responsiveness of beating rat heart myocytes after stationary and non-stationary cultivation
31. Improved patch-clamp techniques for high-resolution current recording from cell and cell-free membrane patches
32. Characterization of the calcium channel state transitions induced by the enantiomers of the 1,4-dihydropyridine Sandoz 202 791 in neonatal rat heart cells. A nonmodulated receptor model
33. Anticonvulsant and related effects of U-54494A in various seizure tests
34. Memantine reduces repetitive action potential firing in spinal cord nerve cell cultures
35. Anticonvulsant drugs: Quantification of effects in convulsant treated spinal cord neurons
36. The biological properties of the optical isomers of propranolol and their effects on cardiac arrhythmias
37. Pharmacological modulation of central monoaminergic systems and influence on the anticonvulsant effectiveness of standard antiepileptics in maximal electroshock seizure
38. Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations
39. Alpha-2 receptors mediate an endogenous noradrenergic suppression of kindling development
40. Some effects of propranolol on the central nervous system
41. Effects of some adrenergic agents on low frequency electroshock seizures
42. Effects of propranolol (a beta adrenergic blocking agent) on some central nervous system parameters
43. Central nervous system pharmacology of propranolol
44. Antiepileptic action of beta-adrenergic blocking drugs: Pronethalol and propranolol
45. Effect of propranolol and nifedipine on maximal electroshock-induced seizures in mice: Individually and in combination
46. Anticonvulsant activity of some β-adrenoceptor blocking agents in mice
47. Audiogenic seizures: Relation to age and mechanisms of monoamine neurotransmission
48. A possible role for beta-adrenergic receptors in the expression of audiogenic seizures
49. Role of β-adrenoceptors in the anticonvulsant effect of propranolol on leptazol-induced convulsions in rats
50. β-Adrenergic blocking agents. II. Propranolol and related 3-amino-1-naphthoxy-2-propanols
51. Some cardiovascular effects of timolol a new β-adrenergic blocking agent
52. Hypertension: Which beta-blocker?
53. Rapid decrease in rat brain beta adrenergic receptor binding during combined antidepressant alpha-2 antagonist treatment
54. Antiepileptic drug actions
55. The pharmacological basis of antiepileptic drug action
56. Comparative anticonvulsant and mechanistic profile of the established and newer antiepileptic drugs
57. Effect of propranolol on the fast inward sodium current in frog atrial muscle
58. A kinetic study of effects of propranolol and N-propylajmaline on the rate of rise of action potential in guinea pig papillary muscles
59. Fast frequency-dependent block of action potential upstroke in rabbit atrium by small anesthetics
60. Effects of nipradilol (K-351) on the electrophysiological properties of canine cardiac tissues: Comparison with propranolol and sotalol
61. Effects of propranolol and a number of its analogues on sodium channels
62. Effects of various antianginal drugs on sodium influx in rat brain synaptosomes and in rat heart muscle cells in culture
63. + channels: Comparison with other β-adrenoceptor antagonists
64. Structure and function of voltage-gated ion channels
65. Structure and function of voltage-dependent sodium channels: Comparison of brain II and cardiac isoforms
66. Selective localization of cardiac SCN5A sodium channels in limbic regions of rat brain
67. The cardiac sodium channel mRNA is expressed in the developing and adult rat and human brain
68. Pharmacology of diphenylhydantoin and carbamazepine action on voltage-sensitive sodium channels
69. Effects of chlordiazepoxide, chlorpromazine, diazepam, diphenylhydantoin, flunitrazepam and haloperidol on the voltage-dependent sodium current in isolated mammalian brain neurons
70. Zur Pharmakologie von (±)-1-[4-Cyclohexylureidophenoxy]- 2 - hydroxy - 3 - tert. - butylaminopropran (Talinolol, Cordanum®, 02-115)
71. Further analysis of inhibitory effects of propranolol and local anaesthetics on the calcium current in Helix neurones
72. Wirkung von (-)- und (+)-Propranolol auf den Kalzium-Einwätsstrom klonierter Neuroblastom x Gliom-Hybridzellen
73. Zur Pharmakokinetik von Propranolol
74. Pharmacology of β-blockers: Classical aspects and recent developments
75. The clinical importance of cardioselectivity and lipophilicity in beta blockers
76. Betablocker in der Psychiatrie-eine klinische Übersicht
77. Einfluß von (+)- und (-)-Propranolol in höheren Dosierungen auf ausgewählte Herz-Kreislauf-Parameter bei der Ratte
78. The effects of propranolol on spontaneous and experimental hypertension in the rat
79. Treatment of valproate tremors
80. A pharmacokinetic study to determine the drug interaction between valproate and propranolol
81. Complete atrio-ventricular conduction block during complex partial seizure
82. Interictal heart rate patterns in partial seizure disorders
83. Sudden unexpected death associated with seizures: Analysis of 66 cases
84. Mortality in patients with epilepsy: A study of patients in long term residential care
85. Cardioprotective effect of d-propranolol in ischemic-reperfused isolated rat hearts
86. Changes in seizure threshold following ECS and bicuculline-induced convulsions